Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 12:38 pm Sale | 2026-03-31 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP PLC JHG | 4,196,409 6.900% | -1,154,044 (-21.57%) | Filing History |
| 2026-05-12 11:18 am Sale | 2026-03-31 | 13G | JANUX THERAPEUTICS INC JANX | STATE STREET CORP STT | 2,464,017 4.100% | -1,389,934 (-36.07%) | Filing History |
| 2026-05-06 11:23 am Sale | 2026-03-31 | 13G | JANUX THERAPEUTICS INC JANX | FMR LLC | 2,535,724 4.200% | -976,660 (-27.81%) | Filing History |
| 2026-04-29 5:31 pm Unchanged | 2026-04-28 | 13G | JANUX THERAPEUTICS INC JANX | Point72 Asset Management, L.P. | 3,069,759 5.000% | 0 (Unchanged) | Filing History |
| 2026-04-29 5:30 pm Purchase | 2026-04-28 | 13G | JANUX THERAPEUTICS INC JANX | Point72 Asset Management, L.P. | 3,069,759 5.000% | 3,069,759 (New Position) | Filing History |
| 2026-02-17 4:34 pm Sale | 2025-12-31 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP PLC JHG | 5,350,453 8.900% | -683,496 (-11.33%) | Filing History |
| 2026-02-09 06:43 am Purchase | 2025-12-31 | 13G | JANUX THERAPEUTICS INC JANX | STATE STREET CORP STT | 3,853,951 6.400% | 3,853,951 (New Position) | Filing History |
| 2026-02-06 4:23 pm Purchase | 2026-02-03 | 13G | JANUX THERAPEUTICS INC JANX | Prosight Management LP | 3,157,220 5.300% | 3,157,220 (New Position) | Filing History |
| 2026-01-08 09:09 am Sale | 2025-12-31 | 13G | JANUX THERAPEUTICS INC JANX | FMR LLC | 3,512,384 5.800% | -4,312,290 (-55.11%) | Filing History |
| 2025-11-07 12:10 pm Purchase | 2025-10-31 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP PLC JHG | 6,033,949 10.000% | 1,573,617 (+35.28%) | Filing History |
| 2025-08-14 4:31 pm Sale | 2025-06-30 | 13G | JANUX THERAPEUTICS INC JANX | Paradigm BioCapital Advisors LP | 2,920,258 4.900% | -595,728 (-16.94%) | Filing History |
| 2025-08-14 11:26 am Sale | 2025-06-30 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP PLC JHG | 4,460,332 7.500% | -138,205 (-3.01%) | Filing History |
| 2025-08-12 09:05 am Sale | 2025-06-30 | 13G | JANUX THERAPEUTICS INC JANX | Adage Capital Management, L.P. | 2,525,000 4.270% | -536,750 (-17.53%) | Filing History |
| 2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | JANUX THERAPEUTICS INC JANX | BlackRock, Inc. BLK | 3,345,664 5.700% | 3,345,664 (New Position) | Filing History |
| 2025-05-14 12:25 pm Purchase | 2025-03-31 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP PLC JHG | 4,598,537 7.800% | 1,036,135 (+29.09%) | Filing History |
| 2025-03-10 4:33 pm Purchase | 2025-03-06 | 13D | JANUX THERAPEUTICS INC JANX | RA Capital Management, L.P. | 11,971,377 19.900% | 1,528,196 (+14.63%) | Filing History |
| 2025-02-14 4:41 pm Purchase | 2024-12-31 | 13G | JANUX THERAPEUTICS INC JANX | Paradigm BioCapital Advisors LP | 3,515,986 6.000% | 907,412 (+34.79%) | Filing History |
| 2025-02-14 11:24 am Purchase | 2024-12-31 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP PLC JHG | 3,562,402 6.100% | 1,724,611 (+93.84%) | Filing History |
| 2025-02-12 09:30 am Purchase | 2024-12-31 | 13G | JANUX THERAPEUTICS INC JANX | Adage Capital Management, L.P. | 3,061,750 5.310% | 3,061,750 (New Position) | Filing History |
| 2024-11-14 4:24 pm Sale | 2024-09-30 | 13G | JANUX THERAPEUTICS INC JANX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -4,579,818 (Position Closed) | Filing History |